HLA-matched related donor hematopoietic stem cell transplantation is a suitable treatment in adolescents and adults with sickle cell disease: Comparison of myeloablative and non-myeloablative approaches
1 Hematology Unit for Adolescents and Young Adults, Saint Louis Hospital, Paris, France.
2 Pediatric Immuno-Hematology, Necker Hospital, Paris, France.
3 Internal Medicine and Clinical Immunology, Conception Hospital, Marseille, France.
4 Internal Medicine, Martigues Hospital, Martigues, France.
5 Pediatric Immuno-Hematology, Robert Debré Hospital, Paris, France.
6 Biotherapy Unit, Necker Hospital, Paris, France.
7 Department of Hematology, Henri Mondor Hospital, Créteil, France.
8 Pediatrics Unit, Charles Nicolle Hospital, Rouen, France.
9 Department of Hematology, Gustave Roussy Hospital, Villejuif, France.
10 Department of Hematology, CHU Grenoble, Grenoble, France.
11 Hemato-Oncology and Transplantation Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
12 Department of Hematology, Pitié Salpetrière Hospital, Sorbonne University, Paris, France.
13 French Sickle Cell Referral Center, Internal Medicine Department, Georges Pompidou European Hospital, and Université de Paris, Paris, France.
14 Pediatric Department, Sickle Cell Referral Center, Centre Hospitalier Intercommunal de Créteil, France and Inserm U955, Université Paris XII, Créteil, France.